E
Eugene Braunwald
Researcher at Brigham and Women's Hospital
Publications - 1758
Citations - 278949
Eugene Braunwald is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Myocardial infarction & TIMI. The author has an hindex of 230, co-authored 1711 publications receiving 264576 citations. Previous affiliations of Eugene Braunwald include Boston University & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
The Use of Ascorbate Dilution Curves in Cardiovascular Diagnosis Applications of a Technic for Direct Intravascular Detection of Indicator
TL;DR: Observations in 90 patients have indicated that the contours of the dilution curves are essentially identical to indocyanine-green dye-dilution curves, except for diminished peripheral recirculation peaks.
Journal ArticleDOI
Coronary plaque erosion: recognition and management.
TL;DR: In this issue of iJACC, Prati et al present their findings from a series of pilot trials on the use of EMMARM, a novel and scalable approaches for evaluating the impact of EMT on central nervous system function.
Journal ArticleDOI
Regional Hemodynamic Effects of a Digitalis Glycoside in the Conscious Dog with and without Experimental Heart Failure
TL;DR: In the normal conscious dog, ouabain causes vasoconstriction in the regional vascular beds, apparently by its direct vascular action, and, in addition, a cholinergically mediated vasodilatation in the mesenteric bed.
Journal ArticleDOI
Resting Ventricular-Vascular Function and Exercise Capacity in Heart Failure with Preserved Ejection Fraction: A RELAX Trial Ancillary Study
Selma F. Mohammed,Barry A. Borlaug,Steven McNulty,Gregory D. Lewis,Grace Lin,Rosita Zakeri,Marc J. Semigran,Martin M. LeWinter,Adrian F. Hernandez,Eugene Braunwald,Margaret M. Redfield +10 more
TL;DR: In heart failure with preserved ejection fraction, potentially modifiable factors (obesity, anemia, and chronotropic incompetence) are strongly associated with exercise capacity, whereas resting measures of ventricular and vascular structure and function are not.
Journal ArticleDOI
Pharmacokinetics and pharmacodynamics of tenecteplase: results from a phase II study in patients with acute myocardial infarction
Nishit B. Modi,NL Fox,Fong-Wong Clow,Paul Tanswell,Christopher P. Cannon,Frans Van de Werf,Eugene Braunwald +6 more
TL;DR: Investigation of the dose‐ranging pharmacokinetics and pharmacodynamics of intravenous bolus tenecteplase compared with intravenous alteplase recombinant t‐PA in patients with acute myocardial infarction found that weight‐adjusted dosing of tenectEplase may optimize the therapeutic regimen ofTenectePLase.